Foundayo vs HealthRX

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Foundayo vs HealthRX: Overview

Choosing between Foundayo and HealthRX for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Foundayo focuses on orforglipron at $149/month with a rating of 9.2/10. HealthRX also provides both semaglutide and tirzepatide at $133/month with a 8.5/10 rating.

With only a $16/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$16/mo
Rating Difference
0.7
Winner
Foundayo
Best For
Quality

Foundayo

View full Foundayo review →
Rating
9.2/10Better
Monthly Price
$149
Medications
orforglipron

Pros

  • The first and only FDA-approved GLP-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 April 2026
  • In the ATTAIN-1 trial, participants on the highest dose who stayed on treatment lost an average of 27.3 pounds (12.4% of body weight) against 2.2 pounds (0.9%) on placebo
  • Counting everyone randomised regardless of whether they finished, the average was still 25 pounds (11.1%) versus 5.3 pounds (2.1%) on placebo - Lilly published both numbers rather than only the flattering one
  • A once-daily tablet, so there is no injection, no needle disposal and no refrigeration to organise
  • Self-pay pricing is published up front at $149 per month for the lowest dose through LillyDirect, with free home delivery
  • Eligible people with commercial insurance may pay as little as $25 per month with the Foundayo savings card
  • Eligible Medicare Part D patients may be able to get it for $50 per month from as early as 1 July 2026 - a rarity in this category
  • Lilly reported reductions in waist circumference, non-HDL cholesterol, triglycerides and systolic blood pressure across all doses
  • It is a small-molecule (non-peptide) GLP-1, which is why it can be manufactured as a pill rather than an injection

Cons

  • Weight loss is meaningfully lower than the best injectables. 12.4% at the top dose sits below tirzepatide territory, so if maximum weight loss is the goal an injection still wins
  • It carries the class boxed warning: it may cause thyroid tumours including thyroid cancer, and must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
  • Should not be used alongside another GLP-1 receptor agonist
  • Common side effects include nausea, constipation, diarrhoea, vomiting, indigestion, abdominal pain, headache, fatigue, heartburn, gas and hair loss
  • Serious risks in the label include pancreatitis, dehydration leading to kidney problems, gallbladder problems, severe allergic reactions and aspiration risk under anaesthesia
  • Safety and effectiveness in children have not been established
  • $149 is the price of the lowest dose only - higher doses cost more, and the $25 and $50 figures depend on insurance eligibility rather than being available to everyone
  • Very new to market, so there is no long-term real-world safety and adherence record yet
Choose Foundayo

HealthRX

View full HealthRX review →
Rating
8.5/10
Monthly Price
$133Cheaper
Medications
semaglutidetirzepatide

Pros

  • Efficacy claims are cited to the actual trials with duration and source: 'Average 15% body-weight loss at 68 weeks in STEP-1' for semaglutide and 'Average 21% body-weight loss at 72 weeks in pivotal phase-3 trial' for tirzepatide, referencing NEJM 2021, each followed immediately by 'Not FDA-approved'
  • The competitor price comparison is dated and sourced - 'published monthly prices at comparable telehealth clinics, July 2026' and 'Prices as displayed on each clinic's public site' - rather than an unattributed claim of being cheapest
  • LegitScript certification is given with its certificate number (50087439), so it can be independently verified
  • Pricing is low and clearly tiered: compounded semaglutide from $133/mo on a 3-month plan or $99/mo on 12 months, and tirzepatide from $209/mo or $179/mo on 12 months (checked July 27, 2026)
  • Same price at every dose, so titration does not raise the bill
  • Full refund if a licensed provider does not approve you, and the site states outright that paying does not guarantee a prescription
  • Cancel anytime 'in one click', with free overnight cold-chain shipping and availability in all 50 states
  • The 503A regulatory category is named specifically rather than the vaguer 'FDA-registered facility' language competitors prefer

Cons

  • The '4.8 · 12,000+ members' rating shown in the header has no traceable source - we found no Trustpilot profile for the domain and no other public review platform carrying it
  • The advertised prices are plan prices, not month-to-month rates. '$133/mo' is the 3-month plan and '$99/mo' requires committing to a full year; no single-month price is displayed
  • Committing 12 months upfront to a compounded medication means paying for a year before you know how you tolerate it
  • No BBB profile or independent complaint record exists to check the service against
  • No published customer phone number or support hours
  • The competitor comparison, while dated and sourced, is still marketing produced by the company that benefits from it
  • As with every compounded GLP-1, the trial figures quoted come from the branded medicines rather than the compounded product actually dispensed - HealthRX says so, but the numbers still headline the page
Choose HealthRX

Feature-by-feature comparison

FeatureFoundayoHealthRX
Monthly Price$149$133
Rating9.2/108.5/10
Medicationsorforglipronsemaglutide, tirzepatide
Insurance AcceptedYesNo
Support HoursNot publishedNot published
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedFree home delivery via LillyDirect; shipping began 6 April 2026Free overnight shipping, ships cold in 24-48 hours
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up FrequencyAs directed by your prescriberProvider review and ongoing support included
Money-back GuaranteeNone published; this is a prescription medicine, not a subscription serviceFull refund if a licensed provider does not approve you for treatment
Cancellation PolicyPrescription-based - stopping treatment is a decision for you and your prescriberCancel anytime in one click; plan prices are paid upfront for the term selected

Which should you choose?

Choose Foundayo if you:

  • Prefer a higher-rated service (9.2/10 vs 8.5/10)
  • Need insurance coverage for your treatment
  • Value: the first and only fda-approved glp-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 april 2026

Choose HealthRX if you:

  • Want to save $16/month with a more affordable option
  • Want more medication options to choose from
  • Value: efficacy claims are cited to the actual trials with duration and source: 'average 15% body-weight loss at 68 weeks in step-1' for semaglutide and 'average 21% body-weight loss at 72 weeks in pivotal phase-3 trial' for tirzepatide, referencing nejm 2021, each followed immediately by 'not fda-approved'

Website previews

Foundayo

Foundayo website

HealthRX

HealthRX website

Our recommendation

Foundayo comes out ahead with a higher rating of 9.2/10.
Get started with Foundayo

Compare other providers

Compare GLP-1 Brands